295 related articles for article (PubMed ID: 36523779)
1. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.
Lu H; Zhou L; Zhang B; Xie Y; Yang H; Wang Z
Front Med (Lausanne); 2022; 9():939776. PubMed ID: 36523779
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas.
Huang W; Wu Y; Zhu J; Luo N; Wang C; Liu S; Cheng Z
Front Mol Biosci; 2023; 10():963639. PubMed ID: 36825202
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker.
Zhang C; Zeng Y; Guo X; Shen H; Zhang J; Wang K; Ji M; Huang S
Front Genet; 2022; 13():923737. PubMed ID: 35991547
[No Abstract] [Full Text] [Related]
4. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
5. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.
Yao Y; Chen H; Lou M; Chen T
Front Genet; 2023; 14():1071694. PubMed ID: 36755576
[No Abstract] [Full Text] [Related]
6. Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas.
Liu H; Bao X; Zeng Z; Liu W; Li M
Heliyon; 2024 Apr; 10(7):e29212. PubMed ID: 38633656
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas.
Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y
Front Genet; 2022; 13():992995. PubMed ID: 36579333
[No Abstract] [Full Text] [Related]
8. High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD).
Wang L; Cao Y; Guo W; Xu J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):15-24. PubMed ID: 36173462
[TBL] [Abstract][Full Text] [Related]
9. Cuproptosis-related gene
Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
Front Immunol; 2022; 13():999823. PubMed ID: 36225932
[TBL] [Abstract][Full Text] [Related]
10. A Novel Cuproptosis-Related Prognostic Model and the Hub Gene
Zhang K; Yang W; Zhang Z; Ma K; Li L; Xu Y; Qiu J; Yu C; Zhou J; Cai L; Gong Y; Gong K
J Oncol; 2022; 2022():2124088. PubMed ID: 36536785
[TBL] [Abstract][Full Text] [Related]
11. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
Front Genet; 2023; 14():1124439. PubMed ID: 36936439
[No Abstract] [Full Text] [Related]
12. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Feng L; Li G; Li D; Duan G; Liu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
[TBL] [Abstract][Full Text] [Related]
13. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.
Yang L; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Front Pharmacol; 2022; 13():938134. PubMed ID: 36210836
[TBL] [Abstract][Full Text] [Related]
14. A novel cuproptosis-related gene signature to predict prognosis in Glioma.
Zhang M; Liu X; Wang D; Ruan X; Wang P; Liu L; Xue Y
BMC Cancer; 2023 Mar; 23(1):237. PubMed ID: 36915038
[TBL] [Abstract][Full Text] [Related]
15. Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator
Zeng S; Zhang H; Zhang D; Hu X; Song L
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292610
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer.
Li X; Dai Z; Liu J; Sun Z; Li N; Jiao G; Cao H
Front Genet; 2022; 13():969856. PubMed ID: 36226187
[No Abstract] [Full Text] [Related]
17. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.
Dai L; Zhou P; Lyu L; Jiang S
BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959
[TBL] [Abstract][Full Text] [Related]
18. Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma.
Xie D; Huang H; Guo Y; Jiang Z; Kuang Y; Huang H; Liu W; Wang L; Xin Z; Wang B; Ren C; Jiang X
Heliyon; 2024 Mar; 10(5):e26976. PubMed ID: 38463788
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting.
Cai C; Zhou K; Jing J; Ren Y; Weng G; Cen D; Wang X; Huang S
Aging (Albany NY); 2023 Jul; 15(13):6117-6134. PubMed ID: 37432054
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.
Lu H; Zhou L; Zhang B; Xie Y; Yang H; Wang Z
Front Med (Lausanne); 2023; 10():1244638. PubMed ID: 37492249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
